204 related articles for article (PubMed ID: 2438035)
1. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
[TBL] [Abstract][Full Text] [Related]
2. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
Broers JL; Ramaekers FC; Rot MK; Oostendorp T; Huysmans A; van Muijen GN; Wagenaar SS; Vooijs GP
Cancer Res; 1988 Jun; 48(11):3221-9. PubMed ID: 2452687
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in lung cancer pathology.
Broers JL; Klein Rot M; de Leij L; Wagenaar SS; Carney DN; Vooijs GP; Ramaekers FC
Eur J Respir Dis Suppl; 1987; 149():11-8. PubMed ID: 2438150
[TBL] [Abstract][Full Text] [Related]
5. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
6. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytoskeletal structures in hormone producing lung cancer cell cultures.
Broers JL; Gropp C; Bepler G; Rot MK; Beck J; Schaart G; Vooijs GP; Ramaekers FC
Acta Histochem Suppl; 1987; 34():57-75. PubMed ID: 2437618
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin and neurofilament in lung carcinomas.
van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of cluster 1 small cell lung cancer antigen and chromogranin A in lung carcinomas.
Noguchi M; Hirohashi S; Shimosato Y
Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1315401
[TBL] [Abstract][Full Text] [Related]
12. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
13. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
[TBL] [Abstract][Full Text] [Related]
14. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
18. Large cell carcinoma of the lung--ultrastructural and immunohistochemical studies.
Kodama T; Shimosato Y; Koide T; Watanabe S; Teshima S
Jpn J Clin Oncol; 1985 Jun; 15(2):431-41. PubMed ID: 2410641
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6.
Lee I; Radosevich JA; Ma YX; Combs SG; Rosen ST; Gould VE
Cancer Res; 1985 Nov; 45(11 Pt 2):5813-7. PubMed ID: 2414000
[TBL] [Abstract][Full Text] [Related]
20. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
